Research platforms: target- and phenotype-based drug discovery
Array’s world-class research proficiencies are rooted in a 20-year legacy of medicinal chemistry, expertise in X-ray crystallography and a unique end-to-end capability. With one of the industry’s largest proprietary kinase libraries, Array scientists apply an extensive tool kit and institutional knowledge to methodically and simultaneously optimize hits for activity and tolerability.
Array works equally well in target- and phenotype-based drug discovery.
ADME: Absorption, Distribution, Metabolism and Excretion; CMC: Chemistry, Manufacturing and Controls; IND: Investigational New Drug.